SCHEMBL4490410

SCHEMBL4490410

CCOC(=O)NC(=O)/C(C#N)=C/C=C/c1ccc(O)c(O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.59
ALDH1A1 P00352 5/20 0.55
POLB P06746 2/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
PSMD14 O00487 1/20 0.54
EGFR P00533 6/20 0.50
TTR P02766 1/20 0.49
DPP4 P27487 1/20 0.49
RAB9A P51151 1/20 0.48
DNM1 Q05193 6/20 0.46
USP2 O75604 1/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
CYP3A4 P08684 1/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
ALOX12 P18054 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4490417 1.00 MAOB (0.59) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL4471168 0.83 MAOB (0.67) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL4471166 0.83 MAOB (0.67) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL13678405 0.78 MAOB (0.62) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL13678105 0.77 MAOB (0.80) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL13678104 0.77 MAOB (0.63) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL4487080 0.76 MAOB (0.83) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL4487075 0.76 MAOB (0.83) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL13678408 0.76 MAOB (0.59) MAOBALDH1A1POLBMEN1KMT2A
SCHEMBL13678168 0.75 MAOB (0.81) MAOBALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-7598419-B2 Compounds for modulating cell proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2009-10-06 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2007-10-18 US disclosed
EP-1727822-A4 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RES DEV LP (CA) 2007-05-09 EP disclosed
EP-1727822-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC Research and Development Limited Partnership (CA) 2006-12-06 EP disclosed
WO-2005092904-A1 NOVEL COMPOUNDS FOR MODULATING CELL PROLIFERATION HSC RESEARCH AND DEVELOPMENT LIMITED PARTNERSHIP (CA) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070243612-A1 Novel Compounds for Modulating Cell Proliferation MKI67, CCNA1, PCNA MAOB 3511/4885ALDH1A1 546/4885POLB 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.